| Industry
Industry name |
Pharmaceuticals |
| Variance
Full Year Net Profit Variance |
85 |
| Equity
Latest Equity |
16.55 |
| Face Value
Latest Face Value |
1 |
| Reserves
Total Reserve |
1399.78 |
| Dividend
Full Year Dividend % |
150 |
| Sales Turnover
Full Year Net Sales |
1753.96 |
| Net Profit
Full Year Net Profit |
246.68 |
| Full Year CPS
Full Year Cash Per Share |
17.6 |
| Earning Per Share
Full Year Earning Per Share |
14.9 |
| Quarter CPS
Latest quarter Cash Per Share |
0 |
| Latest Quarter Date
Latest Quarter Yrc |
Sep 1, 2026 |
| Latest Quarter Sales
Latest Quarter Net Sales |
576.38 |
| Previous EPS
Previous earnings per share |
0 |
| Book Value
Book value |
85.6 |
| Networth
Full Year Return on Networth |
26.97 |
| Price/Book Value
Price to Book value |
19.380841 |
| Yearly PE ratio
Full Year Price to Earning per share |
111.3 |
| Yearly PC ratio
Full Year Price to Cash Per Share |
94.1 |
| Bse value
BSE Value in lakhs |
801.6 |
| Nse value
NSE Value in lakhs |
11383.96 |
| High
52 week high |
1896 |
| Low
52 week low |
610 |
| Price
NSE Current market price |
1659 |
| CPM
Current market price |
1659 |
| Market cap
BSE / NSE Market Cap |
27454.66 |
| Net profit
Latest Quarter Net Profit |
90.48 |
| Net profit variance
Latest Quarter Net Profit variance |
68 |
| Result year
Trailing latest month |
Sep 1, 2026 |
| TTM Sales
Trailing Twelve 12 month Net Sales |
0 |
| TTM OP
Trailing Twelve 12 month Operating Profit |
0 |
| TTM OPM
Trailing Twelve 12 month Operating Profit Margin |
0 |
| TTM GP
Trailing Twelve 12 month Gross Profit |
473.57 |
| TTM GPM
Trailing Twelve 12 month Gross Profit Margin |
22.55 |
| TTM NP
Trailing Twelve 12 month Net Profit |
0 |
| TTM NPV
Trailing Twelve 12 month Net Profit Variane |
89.44 |
| TTM EPS
Trailing Twelve 12 month EPS |
19.62 |
| TTM PE
Trailing Twelve 12 month PE |
84.53 |
| TTM CPS
Trailing Twelve 12 month CPS |
0 |
| Month CPS
Month Cash Per Share |
0 |
| TTM Depreciation
Trailing Twelve 12 month Depreciation |
0 |
| Equity
Latest Equity |
16.55 |
| LTP
Latest Price (BSE/NSE) |
1659 |
| Gross block
Latest Gross Block |
787.79 |
| Loans
Total loans |
51.64 |
| Advances
Latest Advances for Banks |
0 |
| Net profit asset
Latest Assets |
0 |
| Year OPM
Full Year Operating Profit Margin |
22.8 |
| Year GPM
Full Year Gross Profit Margin |
20.9 |
| Quarter OPM
Latest quater Operation Profit Margin |
25 |
| Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|
| + Sales | 313 | 358 | 352 | 412 | 476 | 514 | 534 | 576 |
| YOY Sales Growth % | 11% | 39% | 52% | 43% | 52% | 40% | ||
| Gross Sales | 313 | 358 | 352 | 412 | 476 | 514 | 534 | 576 |
| + Expenses | 244 | 286 | 273 | 318 | 367 | 395 | 405 | 432 |
| Material Cost % | 42% | 42% | 48% | 43% | 49% | 36% | 30% | 32% |
| Raw Material Cost | 102 | 123 | 134 | 142 | 184 | 155 | 154 | 175 |
| Change in Inventory | 29 | 27 | 35 | 37 | 48 | 31 | 7 | 8 |
| Manufacturing Cost % | 29% | 33% | 32% | 31% | 30% | 31% | 28% | 28% |
| Employee Cost % | 17% | 16% | 17% | 15% | 14% | 13% | 16% | 16% |
| Other Cost % | -10% | -11% | -19% | -13% | -16% | -3% | 1% | -0% |
| Raw Materials % | 33% | 34% | 38% | 35% | 39% | 30% | 29% | 30% |
| Purchase of Finished Goods % | 8% | 4% | 1% | 5% | 5% | 9% | 4% | 2% |
| Stock Adjustments % | -9% | -7% | -10% | -9% | -10% | -6% | -1% | -1% |
| Other Manufacturing Expenses % | 29% | 33% | 32% | 31% | 30% | 31% | 28% | 28% |
| Operating Profit | 70 | 72 | 79 | 94 | 108 | 119 | 129 | 144 |
| OPM % | 22% | 20% | 22% | 23% | 23% | 23% | 24% | 25% |
| + Other Income | 0 | 0 | 1 | 1 | 4 | 3 | 6 | 2 |
| Miscellaneous Income | 0 | 0 | 1 | 1 | 4 | 3 | 6 | 2 |
| Interest | 8 | 12 | 11 | 11 | 10 | 10 | 9 | 11 |
| Depreciation | 9 | 10 | 10 | 12 | 12 | 12 | 15 | 18 |
| Profit before tax | 53 | 51 | 60 | 72 | 91 | 99 | 110 | 117 |
| + Tax % | 28% | 29% | 27% | 25% | 20% | 22% | 23% | 23% |
| Current Tax | 14 | 12 | 14 | 21 | 18 | 32 | 32 | 25 |
| Deferred Tax | 1 | 2 | 2 | -3 | 0 | -11 | -6 | 1 |
| + Net Profit | 38 | 36 | 43 | 54 | 73 | 77 | 85 | 90 |
| Minority Interest (After Tax) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit After Minority Interest | 38 | 36 | 43 | 54 | 73 | 77 | 85 | 90 |
| EPS in Rs | 2.50 | 2.37 | 2.81 | 3.49 | 4.46 | 4.68 | 5.13 | 5.47 |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| + Sales | 263 | 315 | 314 | 394 | 854 | 1,284 | 1,754 |
| Sales Growth % | 20% | -0% | 25% | 117% | 50% | 37% | |
| Gross Sales | 1,284 | 1,754 | |||||
| + Expenses | 190 | 243 | 387 | 474 | 805 | 1,020 | 1,354 |
| Material Cost % | 15% | 14% | 21% | 25% | 30% | 26% | 28% |
| Raw Material Cost | 42 | 55 | 82 | 149 | 309 | 489 | 634 |
| Change in Inventory | -4 | -10 | -17 | -49 | -53 | -157 | -150 |
| Manufacturing Cost % | 9% | 10% | 23% | 17% | 10% | 10% | 10% |
| Employee Cost % | 16% | 18% | 25% | 25% | 15% | 16% | 15% |
| Other Cost % | 33% | 35% | 55% | 53% | 40% | 27% | 25% |
| Raw Materials % | 16% | 17% | 26% | 38% | 36% | 38% | 36% |
| Purchase of Finished Goods % | 6% | 5% | |||||
| Stock Adjustments % | 1% | 3% | 5% | 13% | 6% | 12% | 9% |
| Power & Fuel % | 3% | 2% | 3% | 4% | 2% | 2% | 1% |
| Other Manufacturing Expenses % | 5% | 8% | 19% | 13% | 7% | 9% | 8% |
| Selling & Administration % | 25% | 27% | 41% | 26% | 26% | 27% | 24% |
| Miscellaneous Expenses % | 5% | 3% | 2% | 2% | 1% | 0% | 1% |
| Operating Profit | 73 | 72 | -73 | -80 | 49 | 264 | 400 |
| OPM % | 28% | 23% | -23% | -20% | 6% | 21% | 23% |
| + Other Income | 18 | 10 | 17 | 25 | 19 | 4 | 8 |
| Miscellaneous Income | 4 | 8 | |||||
| Interest | 6 | 9 | 10 | 19 | 31 | 37 | 42 |
| Depreciation | 18 | 29 | 34 | 36 | 39 | 37 | 45 |
| Profit before tax | 195 | 321 | |||||
| + Tax % | 31% | 23% | |||||
| Current Tax | 28 | 21 | 4 | 8 | 13 | 62 | 85 |
| Deferred Tax | -4 | 11 | -3 | -2 | -2 | -2 | -11 |
| + Net Profit | 134 | 247 | |||||
| Profit Growth % | 84% | ||||||
| Net Profit After Minority Interest | 49 | 31 | -67 | -17 | 91 | 134 | 247 |
| EPS in Rs | 97.46 | 60.53 | -132.38 | -33.31 | 5.98 | 8.72 | 14.95 |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Equity Capital | 5 | 5 | 5 | 5 | 15 | 15 | 17 |
| Reserves | 335 | 369 | 300 | 281 | 370 | 526 | 1,272 |
| + Borrowings | 30 | 93 | 175 | 320 | 425 | 418 | 311 |
| Secured Borrowings | 30 | 93 | 169 | 318 | 396 | 393 | 259 |
| Unsecured Borrowings | 0 | 0 | 6 | 2 | 28 | 24 | 52 |
| + Other Liabilities | 60 | 71 | 79 | 144 | 300 | 493 | 727 |
| Current Liabilities | 52 | 68 | 78 | 140 | 263 | 449 | 708 |
| Provisions | 12 | 1 | 2 | 23 | 56 | 164 | 237 |
| Other liability items | 8 | 6 | 1 | 3 | 37 | 43 | 19 |
| Total Liabilities | 430 | 538 | 560 | 750 | 1,109 | 1,451 | 2,327 |
| + Fixed Assets | 157 | 188 | 193 | 199 | 307 | 327 | 532 |
| Gross Block | 218 | 278 | 317 | 359 | 492 | 540 | 788 |
| Accumulated Depreciation | 61 | 90 | 124 | 160 | 185 | 213 | 256 |
| CWIP | 2 | 6 | 3 | 25 | 10 | 7 | 41 |
| Investments | 19 | 14 | 0 | 0 | 0 | 0 | 27 |
| + Other Assets | 252 | 330 | 364 | 526 | 793 | 1,118 | 1,728 |
| Inventories | 38 | 62 | 90 | 167 | 300 | 522 | 729 |
| Trade receivables | 140 | 136 | 140 | 225 | 301 | 324 | 509 |
| Cash Equivalents | 36 | 86 | 53 | 59 | 58 | 116 | 346 |
| Loans n Advances | 36 | 45 | 47 | 50 | 104 | 104 | 111 |
| Other asset items | 3 | 1 | 35 | 24 | 28 | 52 | 33 |
| Total Assets | 430 | 538 | 560 | 750 | 1,109 | 1,451 | 2,327 |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| + Cash from Operating Activity | 5 | 62 | -63 | -75 | 21 | 159 | 205 |
| Profit from Operations | 102 | 99 | -39 | 35 | 174 | 288 | 428 |
| Working Capital Changes | -70 | -4 | -16 | -108 | -135 | -90 | -115 |
| Profit Before Tax & Extraordinary Items | 74 | 63 | -66 | -11 | 103 | 195 | 321 |
| Depreciation | 18 | 29 | 34 | 36 | 39 | 37 | 45 |
| Interest (Net) | 4 | 7 | 8 | 18 | 30 | 35 | 35 |
| Dividend Received | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit / Loss on Sale of Assets | 0 | 0 | 0 | 0 | 0 | -1 | 1 |
| Profit / Loss on Sale of Investments | -2 | 0 | -1 | 0 | 0 | 0 | 0 |
| Provisions & Write-offs (Net) | 10 | 2 | 1 | 0 | 1 | 0 | 0 |
| Profit / Loss in Forex | -10 | -1 | -16 | -15 | -4 | -1 | 0 |
| Receivables | -61 | 3 | 1 | -74 | -67 | -21 | -180 |
| Inventories | -17 | -24 | -27 | -78 | -127 | -221 | -207 |
| Trade Payables | -1 | 15 | 24 | 40 | 69 | 63 | 136 |
| Direct Taxes Paid | -27 | -33 | -8 | -2 | -18 | -39 | -109 |
| + Cash from Investing Activity | -84 | -46 | -46 | -32 | -68 | -65 | -407 |
| Purchase of Fixed Assets | -59 | -71 | -55 | -44 | -56 | -70 | -229 |
| Sale of Fixed Assets | 0 | 0 | 0 | 0 | 0 | 2 | 0 |
| Purchase of Investments | -13 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sale of Investments | 8 | 6 | 14 | 0 | 0 | 0 | 0 |
| Interest Received | 2 | 2 | 0 | 0 | 0 | 0 | 0 |
| Dividend Received | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Others | -23 | 17 | -6 | 12 | -13 | -1 | -179 |
| + Cash from Financing Activity | 80 | 52 | 63 | 123 | 44 | -40 | 283 |
| Proceeds from Issue of Shares | 103 | 0 | 0 | 0 | 0 | 8 | 483 |
| Proceeds from Other Long-Term Borrowings | 3 | 57 | 40 | 57 | 35 | 4 | 125 |
| Proceeds from Short-Term Borrowings | 5 | 24 | 48 | 100 | 68 | 25 | 0 |
| Repayment of Long-Term Borrowings | -25 | -18 | -11 | -13 | -25 | -34 | -50 |
| Repayment of Short-Term Borrowings | 0 | 0 | 0 | 0 | 0 | 0 | -228 |
| Repayment of Financial Liabilities | 0 | -1 | -3 | -4 | -4 | -10 | -11 |
| Dividend Paid | 0 | -1 | -1 | 0 | 0 | 0 | 0 |
| Interest Paid | -6 | -9 | -9 | -17 | -30 | -33 | -37 |
| Net Cash Flow | 1 | 67 | -45 | 16 | -4 | 54 | 81 |